Literature DB >> 16109440

Gene expression profiling of in vitro radiation resistance in cervical carcinoma: a feasibility study.

Devansu Tewari1, Bradley J Monk, Muthana S Al-Ghazi, Ricardo Parker, J Denis Heck, Robert A Burger, John P Fruehauf.   

Abstract

OBJECTIVE(S): To determine the feasibility of integrating an in vitro chemo-radiation response assay (IVRRA) with a gene microarray system to investigate the molecular patterns of expression that contribute to radiation resistance in cervical cancer.
METHODS: Viable primary untreated cervical cancer specimens were obtained and exposed to gamma irradiation at a dose of 3 Gy in the IVRRA to determine in vitro radiation sensitivity. RNA was purified for microarray analysis with the Affymetrix Human Genome U95A Array carrying more than 12,000 gene probes. Gene expression analysis was performed, and specimen transcript patterns were correlated with radiation response using an iteration analysis model and Pearson's correlation coefficient.
RESULTS: A feasibility set of eight tumor specimens was studied. Tumors were classified into 4 extreme (ERR), 2 intermediate (IRR) and 2 low radiation resistance (LRR) categories. An intrinsic radiation response gene set of 54 genes transcripts with 100% accuracy for the classification of each tumor's radiation response category was identified. CONCLUSION(S): Gene sets associated with in vitro radiation response profiles in cervical cancer can be generated using the IVRRA and microarray technology. This has direct applications to the study of the biological pathways contributing to radiation resistance and may lead to the development of alternative treatment modalities. The potential of these technologies for cancers in which radiotherapy is employed warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16109440     DOI: 10.1016/j.ygyno.2005.05.043

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  MIIP gene expression is associated with radiosensitivity in human nasopharyngeal carcinoma cells.

Authors:  Hong-Ping Zhou; Lu-Xi Qian; Nan Zhang; Jia-Jia Gu; Kai Ding; Jing Wu; Zhi-Wei Lu; Ming-Yu Du; Hong-Ming Zhu; Jian-Zhong Wu; Xia He; Li Yin
Journal:  Oncol Lett       Date:  2018-04-18       Impact factor: 2.967

2.  Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: a Southwest Oncology Group Study.

Authors:  Leslie M Randall; Bradley J Monk; James Moon; Ricardo Parker; Muthana Al-Ghazi; Sharon Wilczynski; John P Fruehauf; Maurie Markman; Robert A Burger
Journal:  Gynecol Oncol       Date:  2010-09-16       Impact factor: 5.482

Review 3.  Overview of microarray analysis of gene expression and its applications to cervical cancer investigation.

Authors:  Angel Chao; Tzu-Hao Wang; Chyong-Huey Lai
Journal:  Taiwan J Obstet Gynecol       Date:  2007-12       Impact factor: 1.705

4.  RadSigBench: a framework for benchmarking functional genomics signatures of cancer cell radiosensitivity.

Authors:  John D O'Connor; Ian M Overton; Stephen J McMahon
Journal:  Brief Bioinform       Date:  2022-03-10       Impact factor: 11.622

5.  A multiple genomic data fused SF2 prediction model, signature identification, and gene regulatory network inference for personalized radiotherapy.

Authors:  Qi-En He; Yi-Fan Tong; Zhou Ye; Li-Xia Gao; Yi-Zhi Zhang; Ling Wang; Kai Song
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

6.  Investigation of radiosensitivity gene signatures in cancer cell lines.

Authors:  John S Hall; Rohan Iype; Joana Senra; Janet Taylor; Lucile Armenoult; Kenneth Oguejiofor; Yaoyong Li; Ian Stratford; Peter L Stern; Mark J O'Connor; Crispin J Miller; Catharine M L West
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.